/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

Cambridge, United States

Alnylam Pharmaceuticals develops RNAi therapeutics.

Healthcare & Biotech

Alnylam Pharmaceuticals, based in Cambridge, United States, has 2 investors on file, among them ARCH Venture Partners and Atlas Venture. Its site was last checked 6 Nov 2026: site answers.

alnylam.com

Investors

2 investors on file
InvestorEvidenceType
ARCH Venture PartnersPortfolio pageVenture capital
Atlas VenturePortfolio pageVenture capital

In the news

2 headlines naming Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc. (ALNY) Investigation Notice: Levi & Korsinsky ...pr-inside.comUNIVEST FINANCIAL Corp Acquires 12,924 Shares of Alnylam Pharmaceuticals, Inc. $ALNYthemarketsdaily.comExit

Each headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.

More from ARCH Venture Partners

113 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (91%), AI & Machine Learning (3%), Industrial & Manufacturing (2%).

Agios PharmaceuticalsAgios develops therapies for people with rare diseases, with a focus o…AledadeAledade provides actionable insights and expert support for clinicians…Altos LabsAltos Labs is focused on understanding how to translate the science of…ArsenalbioArsenal Biosciences, Inc. is a cell therapy company that discovers and…Aspen NeuroscienceAspen Neuroscience develops personalized cell therapies for Parkinson'…

See ARCH Venture Partners' full profile · Who invests alongside it

More from Atlas Venture

52 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (93%), Industrial & Manufacturing (2%), Robotics & Hardware (2%).

Accent TherapeuticsAccent Therapeutics develops small molecule therapeutics for patients …Bicycle TherapeuticsBicycle Therapeutics is developing precision-guided therapeutics to ta…Cogent BiosciencesCogent Biosciences conducts clinical trials and develops treatments fo…ComancheComanche Biopharma is a biopharmaceutical company developing an invest…Day One BiopharmaceuticalsThe company develops cancer therapies for children and adults

See Atlas Venture's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Alnylam Pharmaceuticals and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when ARCH Venture Partners adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/alnylam.com/investors

# also
GET /v1/companies/alnylam.com
GET /v1/companies/alnylam.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing